Showing 171-180 of 351 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Identifying pharmaceuticals for enhancing metabolic maturity of stem cell derived islets | Regents of the University of Michigan | Lonnie Shea | Cures | 01-December-2024 to 30-November-2027 | $1.125.000,00 |
| Longitudinal non-inasive monitoring of vascular remodeling using oxygen-sensing nanoprobes | Regents of the University of Michigan | Maria Coronel | Cures | 01-March-2025 to 28-February-2030 | $1.000.000,00 |
| GeLite: Glowing Engineered Luminescent Microgels for Transplant Evaluation | Regents of the University of Michigan | Maria Coronel | Cures | 01-June-2024 to 31-October-2026 | $200.000,00 |
| University of Michigan and OHSU Breakthrough T1D Cardio-Renal Center of Excellence : Accelerating Breakthrough Targeted New Therapies for Cardio-Renal Complications for People with T1D | Regents of the University of Michigan | Matthias Kretzler | Improving Lives | 01-May-2025 to 30-April-2028 | $2.842.434,27 |
| Repurposing LRRK2 inhibitors for β cell protection in T1D | Regents of the University of Michigan | Scott Soleimanpour | Cures | 01-September-2023 to 31-August-2027 | $750.000,00 |
| Preservation of iPS-derived Beta islet aggregates | Regents of the University of Minnesota | Allison Hubel | Cures | 01-May-2026 to 30-April-2028 | $599.662,15 |
| Mechanistic Etiologies Underlying the Impact of Verapamil to Preserve β Cell Function in Type 1 diabetes | Regents of the University of Minnesota | Antoinette Moran | Cures | 01-September-2024 to 30-June-2027 | $643.946,00 |
| Hybrid Closed Loop Therapy for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study (CLVerEX) | Regents of the University of Minnesota | Antoinette Moran | Cures | 01-April-2023 to 31-March-2026 | $1.652.469,26 |
| Growing Beta Cell Replacement in T1D by Tolerizing Stem Cell-Derived Islets | Regents of the University of Minnesota | Bernhard Hering | Cures | 01-August-2025 to 31-July-2027 | $688.430,02 |
| Employing PD-L1-Modified Biomaterials to Induce Islet Allograft Tolerance Following Perihepatic Transplantation in Nonhuman Primates | Regents of the University of Minnesota | Melanie Graham | Cures | 01-April-2025 to 31-March-2027 | $918.744,88 |